Express Pharma

TAKE Solutions opens first pharmacovigilance peer network with PVIndia


PVIndia is a membership-based network of emerging global pharma companies from India to meet and discuss some of the industry’s common challenges in pharmacovigilance

TAKE Solutions announced the first meet of PVIndia, a unique pharmacovigilance peer network, organised and managed by one of TAKE’s Life Sciences division, Navitas. PVIndia is a membership – based network of emerging global pharmaceutical companies from India to meet and discuss some of the industry’s common challenges in pharmacovigilance (drug safety). PVNet is a neutral platform for heads of drug safety from India to meet where insights can be exchanged and strategies can be developed and shared.

The inaugural meeting was attended by 25 drug safety professionals representing 14 Indian pharma and global pharma companies. The key discussion topics at the event were, global harmonisation of regulations, how companies adapt to a variety of international regulations and inspection readiness. Navitas plans to organise the second edition of PVIndia in October.

Ram Yeleswarapu, President and CEO, TAKE Solutions said, “We are pleased to announce the introduction of our networks to India. The scale and convenience of collaboration facilitated by the network meets will explore and help generate new solutions to the challenges faced by players in the Indian pharma landscape.” He added, “The ambition for PVIndia is to become an active think tank to improve safety practices across India, in order to ensure the ongoing protection of public health and increase awareness of the importance of drug safety amongst healthcare professionals and patients.’’

“I am glad to be a part of the inaugural meet of PVIndia. At times when Indian companies like their colleagues in the US and EU are frequented by inspectors of internal health authorities, there exists significant strain on any organisation. Being prepared for any inspection is a priority for the Indian pharma industry in such scenarios,’’ said Dr K Bangarurajan, Deputy Drugs Controller of CDSCO West. He further added, “PVIndia will help companies to prepare for inspections triggered by these regulations.’’

EP News BureauMumbai

Comments are closed.